{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:42:48Z","timestamp":1793162568889,"version":"4.5.0"},"reference-count":77,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,8]]},"DOI":"10.1001\/jama.2020.21974","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T14:17:51Z","timestamp":1607005071000},"page":"2301","source":"Crossref","is-referenced-by-count":180,"title":["Managing Asthma in Adolescents and Adults"],"prefix":"10.1001","volume":"324","author":[{"given":"Michelle M.","family":"Cloutier","sequence":"first","affiliation":[{"name":"UCONN Health, Farmington, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Dixon","sequence":"additional","affiliation":[{"name":"University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Krishnan","sequence":"additional","affiliation":[{"name":"University of Illinois Hospital and Health Sciences System, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Robert F.","family":"Lemanske","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Pace","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schatz","sequence":"additional","affiliation":[{"name":"Department of Allergy, Kaiser Permanente Medical Center, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jsc200005r3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"Focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.","volume":"146","author":"Expert Panel Working Group of the National Heart, Lung, and Blood Institute","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"jsc200005r11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.7326\/M18-3279","article-title":"Disclosure of interests and management of conflicts of interest in clinical guidelines and guidance statements.","volume":"171","author":"Qaseem","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"jsc200005r12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines, 1: introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"jsc200005r14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2011.12.985","article-title":"Asthma Outcomes Workshop: overview.","volume":"129","author":"Busse","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"jsc200005r15","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jaci.2011.12.983","article-title":"Asthma outcomes: exacerbations.","volume":"129","author":"Fuhlbrigge","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"jsc200005r16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines, 8: rating the quality of evidence\u2014indirectness.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"jsc200005r17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"jsc200005r18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13601-018-0192-0","article-title":"On-demand intermittent beclomethasone is effective for mild asthma in Brazil.","volume":"8","author":"Camargos","year":"2018","journal-title":"Clin Transl Allergy"},{"issue":"20","key":"jsc200005r19","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"issue":"9405","key":"jsc200005r20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","article-title":"Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.","volume":"363","author":"Harrison","year":"2004","journal-title":"Lancet"},{"issue":"7033","key":"jsc200005r21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/bmj.312.7033.748","article-title":"Randomised comparison of guided self management and traditional treatment of asthma over one year.","volume":"312","author":"Lahdensuo","year":"1996","journal-title":"BMJ"},{"issue":"7","key":"jsc200005r22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.200904-0616OC","article-title":"Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.","volume":"180","author":"Oborne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"jsc200005r23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations.","volume":"378","author":"McKeever","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"jsc200005r24","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"issue":"2","key":"jsc200005r25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/resp.12009","article-title":"Budesonide\/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide\/formoterol plus terbutaline in patients with asthma: phase III study results.","volume":"18","author":"Atienza","year":"2013","journal-title":"Respirology"},{"issue":"1","key":"jsc200005r26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"1","key":"jsc200005r27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"9537","key":"jsc200005r28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"jsc200005r29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1183\/09031936.05.00028305","article-title":"Budesonide\/formoterol maintenance and reliever therapy: an effective asthma treatment option?","volume":"26","author":"Vogelmeier","year":"2005","journal-title":"Eur Respir J"},{"issue":"12","key":"jsc200005r30","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.rmed.2007.07.014","article-title":"Budesonide\/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol\/fluticasone.","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir Med"},{"issue":"5","key":"jsc200005r31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/ijcp.2007.61.issue-5","article-title":"Effect of budesonide\/formoterol maintenance and reliever therapy on asthma exacerbations.","volume":"61","author":"Kuna","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"2","key":"jsc200005r32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma.","volume":"128","author":"Bateman","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"jsc200005r33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"1","key":"jsc200005r34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.rmed.2014.09.012","article-title":"The effect of fluticasone furoate\/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.","volume":"109","author":"Lee","year":"2015","journal-title":"Respir Med"},{"issue":"18","key":"jsc200005r35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma.","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"jsc200005r36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study.","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clin Ther"},{"issue":"16","key":"jsc200005r37","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting \u00df-agonist in combination with inhaled corticosteroids in Black adults with asthma: the BELT randomized clinical trial.","volume":"314","author":"Wechsler","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"jsc200005r38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaci.2016.01.011","article-title":"Tiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trial.","volume":"138","author":"Hamelmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"jsc200005r39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial.","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"jsc200005r40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study.","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"jsc200005r41","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy.","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"jsc200005r42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many.","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"jsc200005r43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications.","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"jsc200005r44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.","volume":"176","author":"Shaw","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"jsc200005r45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jaip.2013.07.013","article-title":"Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.","volume":"1","author":"Syk","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9643","key":"jsc200005r46","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(08)61448-8","article-title":"Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.","volume":"372","author":"Szefler","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"jsc200005r47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jaci.2014.07.016","article-title":"Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care.","volume":"135","author":"Honkoop","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"jsc200005r48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1752-699X.2012.00306.x","article-title":"Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.","volume":"7","author":"Pike","year":"2013","journal-title":"Clin Respir J"},{"issue":"5","key":"jsc200005r49","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1067\/mai.2001.119155","article-title":"Home intervention in the treatment of asthma among inner-city children.","volume":"108","author":"Carter","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"jsc200005r50","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2105\/AJPH.2004.042994","article-title":"The Seattle-King County Healthy Homes Project: a randomized, controlled trial of a community health worker intervention to decrease exposure to indoor asthma triggers.","volume":"95","author":"Krieger","year":"2005","journal-title":"Am J Public Health"},{"issue":"11","key":"jsc200005r51","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma.","volume":"351","author":"Morgan","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"jsc200005r52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1090198106290622","article-title":"Evaluation of Community Action Against Asthma: a community health worker intervention to improve children\u2019s asthma-related health by reducing household environmental triggers for asthma.","volume":"35","author":"Parker","year":"2008","journal-title":"Health Educ Behav"},{"key":"jsc200005r53","doi-asserted-by":"crossref","first-page":"S657","DOI":"10.2105\/AJPH.2009.165423","article-title":"Impact of a household environmental intervention delivered by lay health workers on asthma symptom control in urban, disadvantaged children with asthma.","volume":"99","author":"Bryant-Stephens","year":"2009","journal-title":"Am J Public Health"},{"issue":"3","key":"jsc200005r54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0027-9684(15)31243-8","article-title":"Outcomes of a home-based environmental remediation for urban children with asthma.","volume":"100","author":"Bryant-Stephens","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"jsc200005r55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1081-1206(10)61012-5","article-title":"Home environmental intervention in inner-city asthma: a randomized controlled clinical trial.","volume":"95","author":"Eggleston","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"jsc200005r56","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3476(99)70130-7","article-title":"A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study.","volume":"135","author":"Evans","year":"1999","journal-title":"J Pediatr"},{"issue":"10","key":"jsc200005r57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.2016.21048","article-title":"Effect of an integrated pest management intervention on asthma symptoms among mouse-sensitized children and adolescents with asthma: a randomized clinical trial.","volume":"317","author":"Matsui","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"jsc200005r58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1034\/j.1398-9995.2002.23498.x","article-title":"Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study.","volume":"57","author":"Pifferi","year":"2002","journal-title":"Allergy"},{"issue":"9","key":"jsc200005r59","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1398-9995.2005.00862.x","article-title":"Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.","volume":"60","author":"Ameal","year":"2005","journal-title":"Allergy"},{"issue":"5","key":"jsc200005r60","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaci.2006.07.043","article-title":"Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.","volume":"118","author":"Garc\u00eda-Robaina","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"jsc200005r61","first-page":"285","article-title":"Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria.","volume":"53","author":"Kili\u00e7","year":"2011","journal-title":"Turk J Pediatr"},{"issue":"2","key":"jsc200005r62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000368832","article-title":"Assessing the efficacy of immunotherapy with a glutaraldehyde-modified house dust mite extract in children by monitoring changes in clinical parameters and inflammatory markers in exhaled breath.","volume":"165","author":"Lozano","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"jsc200005r63","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1398-9995.1997.tb02157.x","article-title":"A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults.","volume":"52","author":"Olsen","year":"1997","journal-title":"Allergy"},{"issue":"10","key":"jsc200005r64","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT-tablet (ALK) in treatment of asthma--post hoc results from a randomised trial.","volume":"108","author":"de Blay","year":"2014","journal-title":"Respir Med"},{"issue":"16","key":"jsc200005r65","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial.","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"jsc200005r66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/all.12791","article-title":"House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.","volume":"71","author":"Devillier","year":"2016","journal-title":"Allergy"},{"issue":"4","key":"jsc200005r67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.aller.2012.07.004","article-title":"The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial.","volume":"41","author":"Marogna","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"6","key":"jsc200005r68","first-page":"231","article-title":"Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus [in Spanish].","volume":"52","author":"Gomez","year":"2005","journal-title":"Rev Alerg Mex"},{"issue":"8","key":"jsc200005r69","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"issue":"2","key":"jsc200005r70","first-page":"146","article-title":"Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen.","volume":"20","author":"Marogna","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"jsc200005r71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1081-1206(10)60111-1","article-title":"Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.","volume":"102","author":"Marogna","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"13","key":"jsc200005r72","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa064707","article-title":"Asthma control during the year after bronchial thermoplasty.","volume":"356","author":"Cox","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"jsc200005r73","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/rccm.200704-571OC","article-title":"Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma.","volume":"176","author":"Pavord","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"jsc200005r74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2466-11-8","article-title":"Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial.","volume":"11","author":"Thomson","year":"2011","journal-title":"BMC Pulm Med"},{"issue":"6","key":"jsc200005r75","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2013.08.009","article-title":"Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma.","volume":"132","author":"Wechsler","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"jsc200005r76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"issue":"6","key":"jsc200005r77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.2019.19986","article-title":"Outpatient management of chronic asthma in 2020.","volume":"323","author":"Tripple","year":"2020","journal-title":"JAMA"},{"key":"jsc200005r4","volume-title":"Draft Needs Assessment Report for Potential Update of the Expert Panel Report 3 (2007): Guidelines for the Diagnosis and Management of Asthma","author":"National Heart, Lung, and Blood Advisory Council Asthma Expert Working Group","year":"2014"},{"key":"jsc200005r10","doi-asserted-by":"crossref","DOI":"10.17226\/13058","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Graham","year":"2011"},{"key":"jsc200005r1","unstructured":"Global Asthma Network. Global Asthma Report 2018. Accessed October 14, 2020. http:\/\/www.globalasthmanetwork.org"},{"key":"jsc200005r2","unstructured":"National Asthma Education and Prevention Program Third Expert Panel on the Diagnosis and Management of Asthma. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute; August 2007. Accessed October 14, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK7232\/"},{"key":"jsc200005r5","doi-asserted-by":"crossref","unstructured":"Wang? Z, Pianosi? P, Keogh? K, . The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management. Comparative Effectiveness Review No. 197. Rockville, MD: Agency for Healthcare Research and Quality; December 2017. Accessed October 11, 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-nitric-oxide\/research\/","DOI":"10.23970\/AHRQEPCCER197"},{"key":"jsc200005r6","doi-asserted-by":"crossref","unstructured":"Leas? BF, D\u2019Anci? KE, Apter? AJ, Bryant-Stephens? T, Schoelles? K, Umscheid? C. Effectiveness of Indoor Allergen Reduction in Management of Asthma. Comparative Effectiveness Review No. 201. Rockville, MD: Agency for Healthcare Research and Quality; February 2018. Accessed October 11, 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-nonpharmacologic-treatment\/final-report-indoor-allergen-reduction","DOI":"10.23970\/AHRQEPCCER201"},{"key":"jsc200005r7","doi-asserted-by":"crossref","unstructured":"Sobieraj? DM, Baker? WL, Weeda? ER, . Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma. Comparative Effectiveness Review No. 194. Rockville, MD: Agency for Healthcare Research and Quality; March 2018. Accessed October 11, 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-pharmacologic-treatment\/research-2017","DOI":"10.23970\/AHRQEPCCER194"},{"key":"jsc200005r8","unstructured":"Lin? SY, Azar? A, Suarez-Cuervo? C, . The Role of Immunotherapy in the Treatment of Asthma. Comparative Effectiveness Review No. 196. Rockville, MD: Agency for Healthcare Research and Quality; March 2018:22-23. Accessed October 11, 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-immunotherapy\/research\/"},{"key":"jsc200005r9","doi-asserted-by":"crossref","unstructured":"D\u2019Anci? KE, Lynch? MP, Leas? BF, . Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma. Comparative Effectiveness Review No. 202. Rockville, MD: Agency for Healthcare Research and Quality; December 2017. Accessed October 11, 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-nonpharmacologic-treatment\/thermoplasty-systematic-review","DOI":"10.23970\/AHRQEPCCER202"},{"key":"jsc200005r13","unstructured":"Brozek? J, Nowak? A, Kunstman? P, Sch\u00fcnemann? H. GRADEpro Guideline Development Tool (G2DT). Accessed October 11, 2020. https:\/\/gradepro.org\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2773482\/jama_cloutier_2020_sc_200005_1607119485.84248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T17:50:32Z","timestamp":1607536232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2773482"}},"subtitle":["2020 Asthma Guideline Update From the National Asthma Education and Prevention Program"],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":77,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,12,8]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.21974","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,8]]}}}